Moderna begins late-stage study of RSV vaccine using mRNA technology – Reuters
1 min read
Moderna begins late-stage research of RSV injection using mRNA technology – Reuters
Moderna Inc (MRNA.O) claimed on Tuesday it had begun a late-stage research of its vaccine for Respiratory Syncytial Virus (RSV) based upon the same innovation utilized to develop its COVID-19 shots.Read More …